Buy or sell Pear Therapeutics stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Pear Therapeutics Stock
Digital Therapeutics Platform
About Pear Therapeutics Stock
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to help treat disease and enhance the efficacy of pharmaceuticals. The company's platform aims to combine novel digital interventions with drugs to enhance efficacy, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians and cost-effective services for payers. The company has three FDA-approved products for substance use disorders, opioid use disorders, and insomnia.
Pear Therapeutics was founded in 2013 and is headquartered in Boston, Massachusetts. Notable investors include Softbank Vision Fund, Temasek Holdings, and Perceptive Advisors.
Investors
5AM Ventures
Arboretum Ventures
Blue Water Life Science Fund
Bridge Builders Collaborative
Crimsonox Capital
dRx Capital
EDBI
Welltok, Seismic, WuXi NextCODE, Sprinklr, Druva, Pear Therapeutics, Taulia, Aetion, Paxata
Forth Management
Jazz Venture Partners
Pear Therapeutics, Akili Interactive Labs, Pymetrics, Halo Neuroscience
Novartis
Pilot House Ventures
QUAD Investment Management
Sarissa Capital Management
Shanda Group
Temasek Holdings
PharmEasy, Tokopedia, DoorDash, Impossible Foods, Wish, AvidXchange, Farmers Business Network, Noom, Blend, Carbon
Trustbridge Partners
Funding History
| February 2016 | $18.7M |
|---|---|
| December 2017 | $51.0M |
| December 2018 | $64.4M |
| December 2020 | $32.0M |
| December 2020 | $107M |
Management
Chief Executive Officer
Corey McCann
Chief Financial Officer
Chris Guiffre
Press
massdevice - Oct, 13 2021
shar - Oct, 13 2021
drugdeliverybusiness - Sep, 16 2021
drugdeliverybusiness - Jul, 14 2021
ow - Jun, 22 2021
wsj - Jun, 22 2021
buff - Apr, 23 2021
drugdeliverybusiness - Apr, 6 2021
zpr - Apr, 6 2021
mobihealthnews - Mar, 1 2021
drugdeliverybusiness - Feb, 23 2021
medcitynews - Jan, 14 2021
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Pear Therapeutics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
